FDA approves third oncology drug that targets a key genetic driver of cancer, rather than a specific type of tumor

FDA approves third cancer treatment based on a common biomarker across different types of tumors rather than the location in the body where the tumor originated
Source: FDA Center for Drug Evaluation and Research - What's New - Category: Drugs & Pharmacology Authors: Source Type: news